drugset / Trial / NCT04848662
To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.
RandomizedCrossoverOpen-labelTreatment
Summary
To compare the pharmacokinetics of budesonide delivered by BDA MDI to budesonide delivered by Pulmicort Respules in children with Asthma aged 4 to 8 years.
Timeline
- Start
- 2021-05-06
- Primary completion
- 2021-07-05
- Completion
- 2021-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 160 ug | Inhaled |
| Subject | Budesonide | Small molecule | 1 mg | Inhaled |
| Background | Salbutamol | Unknown | 180 ug | Inhaled |